LISI announces sales revenues of €224.4m at March 31, 2011, an increase of 23.7% compared with 2010

- All markets holding up well - Significant increase in business in all divisions - De-consolidation of LISI COSMETICS at January 1, 2011, divestiture confirmed on April 6, 2011

During the first quarter ended on March 31, 2011, the LISI Group generated sales revenues of €224.4m, up by 15.2% on a like-for-like basis. In terms of published data, the increase was 23.7%. The perimeter effect is significant because it incorporates the Acument plants into the LISI AUTOMOTIVE division, the Stryker plant at Hérouville Saint-Clair into the LISI MEDICAL division, as well as the divestiture of LISI COSMETICS for the entire period. The exchange rate effect was not significant over the period.

Although it was not fully able to benefit from the margin on the additional business, the good level of sales for the start of the year provide the LISI Group with encouraging prospects for the remainder of the financial year. The potential for improvement in the results will only be optimized when the aeronautical business in the United States has regained its pre-crisis levels.

The divestiture of LISI COSMETICS, which was confirmed on April 6, will contribute a significant capital gain to the net income of the Group and will reduce the net financial indebtedness. The profit generated will be immediately re-used to finance part of the acquisition cost of Creuzet Aéronautique which is in the process of negotiation.